
    
      This is a multicenter, double-blind, randomized, placebo-controlled study to investigate the
      safety and efficacy of rabeprazole 10 mg in treating frequent heartburn. The study will last
      for up to five weeks and consists of the following three phases: a one to two week screening
      period that includes a one week, single-blind, placebo run-in phase, a two week double-blind,
      randomized treatment phase, and a one week single-blind, placebo follow-up phase.
    
  